Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Purchases PacBio RS Single-Molecule Sequencer

Premium

The Wellcome Trust Sanger Institute has purchased a PacBio RS single-molecule sequencer as part of an expansion of Pacific Biosciences’ early-access program, the company said this week.

Earlier this year, PacBio named its first 10 early-access customers (IS 2/23/2010), all located in North America, several of who have received their instruments.

The Sanger Institute, which is expected to obtain its instrument before the end of the year, is the first European customer that PacBio has disclosed in the expansion of its early-access program beyond North America.

The company plans to ship instruments to a “limited number” of early-access sites outside of North America and previously said it is interested in having testing sites in Europe and Asia.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more